Literature DB >> 9615608

WHO Expert Committee on Biological Standardization. Forty-sixth Report.

.   

Abstract

This report presents the recommendations of a WHO Expert Committee commissioned to coordinate activities leading to the adoption of international requirements for the production and control of vaccines and other biologicals and the establishment of international biological reference materials. The report starts with a discussion of general issues brought to the Committee's attention and provides information on the status and development of reference materials for various antibiotics, antibodies, antigens, blood products, cytokines, endocrinological and related substances and toxins. The second part of the report, of particular relevance to manufacturers and national control authorities, contains the revised list of laboratories approved by WHO for the production of yellow fever vaccine, revised requirements for yellow fever vaccine, an amendment to the General Requirements for the Sterility of Biological Substances, and a summary protocol for the batch release of virus vaccines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9615608

Source DB:  PubMed          Journal:  World Health Organ Tech Rep Ser        ISSN: 0512-3054


  3 in total

Review 1.  Advances and controversies in yellow fever vaccination.

Authors:  Emile F F Jonker; Leonardus G Visser; Anna H Roukens
Journal:  Ther Adv Vaccines       Date:  2013-11

2.  Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes.

Authors:  Myrna C Bonaldo; Samanta M Mello; Gisela F Trindade; Aymara A Rangel; Adriana S Duarte; Prisciliana J Oliveira; Marcos S Freire; Claire F Kubelka; Ricardo Galler
Journal:  Virol J       Date:  2007-10-30       Impact factor: 4.099

Review 3.  A clinician's perspective on yellow fever vaccine-associated neurotropic disease.

Authors:  Elien Lecomte; Guy Laureys; Frederick Verbeke; Cristina Domingo Carrasco; Marjan Van Esbroeck; Ralph Huits
Journal:  J Travel Med       Date:  2020-11-09       Impact factor: 8.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.